Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Reducing taxes on retirement income is crucial for financial health. Explore effective methods to retain more of your earnings.
20,007 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Quantography Labs launches Lock.com in early access, a hardware-free crypto wallet that signs transactions offline be...
Zerohash Europe becomes the first crypto firm to hold both an EMI license and MiCA authorization, expanding stablecoi...
Parag Agrawal’s startup is launching Index to quantify how AI agents use publisher content and to compensate creators...
Ethereum retreats from a rough start to the year, but a key analyst says Crypto Spring has begun. Investors are watch...
Metropolis has surged to a $5 billion valuation after a 2025 funding round, transforming parking networks into a broa...
Target rolls out a broad turnaround, including redesigned carts and a baby concierge service, but investors question ...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Oceaneering International has staged a striking rally, with a fund-backed bet signaling confidence in continued growt...
Two tech giants stand out for investors seeking value in megacap stocks. This guide breaks down strengths, risks, and...
Looking for a meaningful tech stock investment with a modest starting stake? Here is a practical case for Uber as the...